BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 62 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $47,000 | – | 71,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kingstown Capital | 300,000 | $72,000 | 0.11% |
| Telemetry Investments, L.L.C. | 153,694 | $36,000 | 0.06% |
| Kamunting Street Capital Management, L.P. | 158,962 | $38,000 | 0.05% |
| Radcliffe Capital Management, L.P. | 202,950 | $2,001,000 | 0.04% |
| Q Global Advisors, LLC | 300,000 | $72,000 | 0.04% |
| Integrity Capital Management (HK) Ltd | 33,267 | $8,000 | 0.04% |
| Corbin Capital Partners, L.P. | 464,062 | $111,000 | 0.02% |
| HGC Investment Management Inc. | 1,215,782 | $292,000 | 0.02% |
| Segantii Capital Management Ltd | 50,000 | $493,000 | 0.01% |
| Sage Rock Capital Management LP | 286,900 | $69,000 | 0.01% |